Omer Hazan Stars in New Series About Baal Shem Tov on 'Rega TV' Streaming Platform
Israeli actor Omer Hazan, currently undergoing a personal religious strengthening process, has been cast in a new series about Rabbi Israel Baal Shem Tov, the founder of Hasidism. The show will be one of the flagship productions of the new streaming platform "Rega TV." Hazan, 26, is known for his roles in popular Israeli series such as "Shababnikim," "Palmach," "Zigi," and "Ba'alat HaHalomot." Over the past year, he has embraced religious observance, including adopting the practice of "shmirat negiah" (modest physical contact), which led to his dismissal from the play "Charlie and a Half." He has openly shared his spiritual journey and connection to Judaism.
The series will explore key moments in the Baal Shem Tov's life, highlighting his revolutionary ideas and lasting impact on Jewish history and spirituality. Mendy Cohen, director of Rega TV, described the Baal Shem Tov as a foundational figure in Jewish history and emphasized the platform's goal to present his story in a way that resonates with younger audiences while maintaining dramatic quality and historical depth. Cohen also noted that Hazan's personal journey makes him especially suited for the role, as he bridges diverse worlds and appeals to varied audiences.
In recent months, Hazan has been attending Torah classes with his partner and received blessings from Rabbi Yigal Cohen for his spiritual growth. Hazan recently became engaged to Yuval Haziza after a year and a half relationship. This new production aligns with a growing trend of making stories about great Jewish figures accessible to broad audiences through high-quality dramatic content. Rega TV aims to offer Jewish-themed programming with cinematic standards, historical authenticity, and spiritual depth.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.